Leveraging Chatbot to Improve PrEP in the Southern United States
Leveraging Chatbot Technology to Improve PrEP Awareness and Uptake Among Black MSM in the Southern United States
Sponsor: Gilead Sciences
This NA trial investigates HIV Prevention and PrEP Awareness and is currently actively recruiting participants. Gilead Sciences leads this study, which shows 9 recorded versions since 2026 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Feb 2026 — Present [monthly]
Not Yet Recruiting NA
-
Aug 2025 — Feb 2026 [monthly]
Not Yet Recruiting NA
-
May 2025 — Aug 2025 [monthly]
Not Yet Recruiting NA
-
Feb 2025 — May 2025 [monthly]
Not Yet Recruiting NA
-
Sep 2024 — Feb 2025 [monthly]
Not Yet Recruiting NA
▶ Show 4 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Not Yet Recruiting NA
-
Mar 2024 — May 2024 [monthly]
Not Yet Recruiting NA
-
Sep 2023 — Mar 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Gilead Sciences
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .